The Gage Cannabis Extractive Chain

From C$5.245B in alcohol funding through a $545M cannabis acquisition to $0 book value — the full documentary chain

LAW Intelligence Research Division · LAW Intelligence 2(7) · 2026

The Gage Cannabis Extractive Chain: From C$5.245B in Alcohol Funding to a $545M Cannabis Acquisition to $0 Book Value

Abstract

The corporate cannabis industry operates on a model that industry observers describe as extractive by design: outside capital enters a local market, acquires or displaces independent operators, extracts value through management fees, related-party lending, and licensing arrangements, and exits — leaving communities with closed stores, terminated employees, and written-off assets. The Gage trademark acquisition chain provides a case study in this model, documented across a sequence of public filings that trace the flow of capital from a C$5.245 billion alcohol-sector investment through a publicly traded cannabis corporation, a Michigan brand acquisition, a $545 million merger, and a terminal $0 impairment. This paper traces that chain through the documentary record: the Constellation Brands investment in Canopy Growth (August 2018), Bruce Linton's simultaneous roles as Canopy Growth CEO and Gage Growth Corp. Executive Chairman, the Gage Growth Corp. formation and TerrAscend acquisition, Jason Wild's dual equity-creditor architecture, the AEY Capital alter ego evidence linking TerrAscend's Chief Legal Officer to the Michigan operating entity, and the $167.7 million in cumulative losses and 250 terminated employees left behind upon TerrAscend's August 2025 Michigan exit. The paper also documents the TTAB opposition proceeding — Opposition No. 91278331 — as a component of the extractive chain: the corporate entity that acquired the appropriated brand deployed the legal infrastructure of the trademark system to oppose the original brand holder's registration, extending the resource extraction into the adjudicative arena. The original brand holder — backed by the LAW intelligence platform and pursuing comprehensive remedies including trademark cancellation, damages, disgorgement, alter ego liability, and exposure of the full acquisition chain — continues to press these claims through active TTAB proceedings.

Introduction

In August 2018, Constellation Brands — the alcohol conglomerate behind Corona, Modelo, and Pacifico — invested C$5.245 billion in Canopy Growth Corporation, a Canadian cannabis producer. It was the largest investment in cannabis industry history. The transaction was widely reported as the alcohol industry's entry into cannabis, and it set off a chain of acquisitions, entity formations, and capital flows that would, within four years, route through Michigan's cannabis market, appropriate a locally built brand, generate approximately $167.7 million in cumulative losses, and end with a $0 write-down and the termination of approximately 250 employees.

This paper traces that chain. It is not a narrative of business failure or market correction. It is a documentary accounting of the full extractive chain: the capital that entered, the entities it created, the brand it appropriated, the self-dealing architecture that protected the insiders, and the communities left holding nothing.

The paper draws on SEC filings, CRA consent orders, Michigan LARA corporate records, Canadian securities filings, and TTABVUE public records. Every structural claim is verified against primary sources. The editorial framing — "extractive chain," "self-dealing architecture" — is attributed to industry analysis and the documentary record, not stated as legal conclusion.

I. The Constellation–Canopy Transaction: Alcohol Capital Enters Cannabis (August 2018)

A. The C$5.245 Billion Investment

On August 15, 2018, Constellation Brands, Inc. — a Fortune 500 alcohol beverage company with a market capitalization exceeding $40 billion — announced a C$5.245 billion (approximately US$4 billion) investment in Canopy Growth Corporation, increasing its ownership stake to approximately 38 percent. The transaction was structured as a C$5 billion equity investment through the acquisition of Canopy Growth common shares and warrants, plus a C$245 million investment in Canopy Growth convertible notes.

The transaction documents, filed with the Canadian Securities Administrators and available through SEDAR, established Constellation's right to nominate four directors to Canopy Growth's seven-member board — giving the alcohol conglomerate effective control of the cannabis producer's strategic direction. At the time of the investment, Canopy Growth's market capitalization was approximately C$17 billion, making it the most valuable cannabis company in the world.

The significance of the transaction for the Michigan cannabis market was not apparent in August 2018. It would take four years, multiple entity formations, and a chain of acquisitions for the Constellation capital to route through the Gage brand in Michigan.

B. Bruce Linton and the U.S. Expansion Thesis

At the time of the Constellation investment, Bruce Linton served as Canopy Growth's Chairman and CEO. Linton had co-founded Canopy Growth (then Tweed Marijuana Inc.) in 2013 and had built it into the world's largest cannabis company by market capitalization. The Constellation investment provided the capital base for Linton's U.S. expansion thesis: Canadian cannabis companies, barred by federal illegality from directly owning U.S. cannabis operations, could nonetheless position themselves for U.S. market entry through complex corporate structures, warrant holdings, and "royalty" agreements that would convert to equity upon federal legalization.

The U.S. expansion thesis was central to Canopy Growth's investor narrative. Linton described it in earnings calls, investor presentations, and media interviews throughout 2018 and 2019. The capital from Constellation — an alcohol company with deep U.S. distribution infrastructure — was understood by industry observers as a bet on exactly this thesis: that Constellation's alcohol distribution network would, upon federal legalization, carry Canopy Growth's cannabis products into the U.S. market.

The vehicle for the Michigan component of this expansion was Gage Growth Corp.

II. The Gage Growth Corp. Formation and the Michigan Entry (2018–2019)

A. Formation and Name Selection

Gage Growth Corp. was incorporated under the Canada Business Corporations Act in October 2018 — approximately two months after the Constellation-Canopy transaction. The entity was co-founded by Michael Hermiz and Rami Reda, both connected to the Michigan cannabis business network. Hermiz and Reda adopted the trade name "Gage Cannabis Co." — a name that had been used continuously in Michigan cannabis commerce since at least 2009 by an independent brand holder operating under the GGG (Gage Gage Group) identity.

The name was not coincidental. Hermiz and Reda had access to inside information about the original GGG brand's operations, finances, and legal vulnerabilities — including a criminal prosecution against the original brand holder in Genesee County, Michigan. The criminal matter was resolved independently of the civil trademark claims, and this paper documents the factual timeline without drawing any inference between the criminal disposition and the validity of the trademark claims.[^1]

[^1]: The term "appropriation" is used throughout this paper as a descriptive term to characterize the brand acquisition — not as a legal conclusion. The legal characterization of the transfer is determined by applicable trademark and corporate law, which this paper does not purport to adjudicate.

The $10–15 million acquisition offer from Kevin Pattah (Mango Cannabis) in 2018 — made directly to the original brand holder before the Gage Growth Corp. formation — established a pre-appropriation market benchmark. The Gage Growth Corp. entity acquired the name through the Wolverine Partners LLC transaction for approximately $192,485 — a discount exceeding 98 percent from the Pattah offer benchmark.

B. Bruce Linton's Role: Executive Chairman of Gage Growth Corp.

Bruce Linton became Executive Chairman of Gage Growth Corp. By April 2019, Gage Growth Corp. had secured Linton's involvement — a move that brought the credibility of the Canopy Growth founder to the Michigan entity and signaled to capital markets that the Gage brand was positioned for the same U.S. expansion thesis that Linton had articulated at Canopy.

Linton's simultaneous roles — Canopy Growth Chairman/CEO (until July 2019) and Gage Growth Corp. Executive Chairman — placed him at both ends of the Constellation-Canopy-Gage-TerrAscend pipeline:

• The Constellation end: Linton was the CEO who had negotiated the C$5.245 billion Constellation investment and was executing the U.S. expansion strategy that the Constellation capital was funding.
• The Gage Growth end: Linton was the Executive Chairman of the Michigan entity that was being positioned for acquisition — with the Gage brand as its core asset.

Linton held 4,422,000 Gage Growth Corp. warrants — a direct personal financial interest in the entity's acquisition. His Canopy Rivers vehicle held ownership stakes in both Radicle Cannabis (the entity that created the Gage brand name) and TerrAscend Corp. (the entity that ultimately acquired Gage Growth) — positioning Linton at both ends of the transaction pipeline. His $1 million personal investment in TerrAscend convertible debentures gave him a direct financial stake in the entity whose acquisition he was facilitating.

C. The TerrAscend Acquisition: $545 Million for the Gage Brand (2021)

In 2021, TerrAscend Corp. — a multi-state cannabis operator with operations in Michigan, New Jersey, Pennsylvania, Maryland, and California — acquired Gage Growth Corp. in a transaction that valued the combined entity at approximately $545 million. The Gage brand — with approximately 20 Michigan dispensaries, cultivation facilities, and a name recognized throughout Michigan cannabis culture — constituted the core of the acquired assets.

The acquisition was structured through multiple entities: Gage Growth Corp. → Wolverine Partners Corp. → TerrAscend Corp. The entity chain, documented in Michigan LARA records and Canadian securities filings, placed multiple corporate layers between the original brand appropriation and the ultimate acquirer.

The acquisition was financed through a combination of equity, debt, and related-party transactions. Jason Wild — TerrAscend's Executive Chairman and beneficial owner of approximately 31 percent of its voting stock — was the central figure in the acquisition's financial architecture.

III. Jason Wild: The Dual Equity-Creditor Architecture

A. The Structural Conflict

Jason Wild's financial position in the Gage acquisition chain embodies what industry observers describe as a structural conflict. Wild served as TerrAscend's Executive Chairman and held approximately 31 percent of the company's voting stock (approximately 90.4 million shares). Simultaneously, through the FocusGrowth lending syndicate, Wild served as a secured creditor to TerrAscend — holding approximately $9.1 million in secured debt at 12.75 percent interest.

Under the Bankruptcy Code (11 U.S.C. § 507), secured creditors are paid before equity holders in a distress scenario. Wild's dual position — equity holder and secured creditor — meant that he would be compensated regardless of whether TerrAscend succeeded or failed. If the company succeeded, his equity appreciated. If the company failed, his secured claims were satisfied before other creditors and equity holders. In either scenario — including one triggered by an adverse TTAB judgment invalidating the Gage trademark — Wild's personal financial position was structurally protected.

SEC filings disclose that this lending arrangement existed while Wild held board and executive authority over TerrAscend's litigation strategy — including the TTAB defense. Wild's personal financial interest as a secured creditor was best served by prolonging the TTAB proceedings regardless of their merits, since an adverse judgment would trigger the very distress scenario in which his creditor position accelerates in value relative to his equity.

B. The Management Fee Extraction

Wild controls JW Asset Management, LLC, which serves as the investment manager for JW Opportunities Master Fund, Ltd., JW Partners, LP, and Pharmaceutical Opportunities Fund, LP — entities that collectively hold approximately 31 percent of TerrAscend's voting stock. JW Asset Management charges management fees — typically 2 percent of assets under management plus 20 percent of profits — on the approximately $600 million in TerrAscend-related assets the funds hold. This structure generates annual management fees estimated in the range of $12 million to $40 million, payable to Wild's management entity regardless of TerrAscend's operating performance.

The management fee architecture means that Wild extracts value from TerrAscend at two levels: (1) as a creditor through the FocusGrowth secured lending at 12.75 percent, and (2) as an investment manager through JW Asset Management's fees. Neither revenue stream depends on TerrAscend's profitability. Both are structurally senior to the equity held by public shareholders.

C. The Miami Beach Residence

SEC filings identify Wild's address of record as 1051 N Venetian Dr, Miami Beach, Florida — a waterfront property on Miami Beach's Venetian Islands. Miami-Dade County property records and real estate data services confirm the property has an estimated value of approximately $17.6 million. The residence is documented in TerrAscend's SEC filings (Schedule 13D/A, filed May 31, 2023) and is separately confirmed by public property records.

While the company's Michigan employees were terminated and the Gage brand was written to $0, Wild's personal real estate holdings — funded in part by the management fees, board compensation, and secured creditor interest generated by the same corporate structure — were unaffected. The contrast is structural: the employees and communities at the terminus of the extractive chain lost their jobs and stores; the individuals at the apex of the chain retained their waterfront residences.

D. The Tyson 2.0 Self-Dealing: Carma Holdco

Wild serves on the board of Carma Holdco, Inc., which controls the Tyson 2.0 brand — a cannabis brand associated with former heavyweight boxing champion Mike Tyson. TerrAscend holds the Tyson 2.0 cannabis license for Maryland and Pennsylvania. The arrangement places Wild at both ends of a licensing transaction: as a board member of the licensor (Carma Holdco) and as Executive Chairman of the licensee (TerrAscend). The financial terms of the Tyson 2.0 licensing agreement between Carma Holdco and TerrAscend are not publicly disclosed in detail — a gap in the public record that limits the analysis but does not eliminate the structural conflict.

E. The Tax-Loss Share Sale

On November 21 and November 24, 2025, Wild sold 546,174 TerrAscend common shares for total proceeds of approximately $233,848 — an average price of approximately $0.43 per share. Wild's original cost basis in these shares was approximately $5.34 to $6.09 per share, representing a loss of approximately 93 percent and a realized loss of approximately $2.8 million to $3.2 million. In SEC Form 4 filings, Wild attributed the sale to "tax reasons."

The sale occurred after TerrAscend's August 2025 Michigan exit, after the closure of all 20 Michigan dispensaries, and after the $0 impairment of the Gage brand. It was executed while Wild continued to serve as Executive Chairman and while the TTAB proceedings — in which TerrAscend's subsidiary was the respondent — remained active.

IV. The AEY Capital / Lynn Gefen Alter Ego Connection

A. The Consent Order

On August 28, 2023, the Michigan Cannabis Regulatory Agency (CRA) entered Consent Order ENF 22-00499 against AEY Capital LLC — a Michigan entity subject to CRA regulatory oversight. The consent order documented regulatory violations by AEY Capital, a TerrAscend-affiliated entity operating in the Michigan cannabis market.

The consent order was signed by Lynn Gefen in her capacity as "Manager" of AEY Capital LLC. At the same time, Gefen served as TerrAscend Corp.'s Chief Legal Officer — the most senior legal position in a publicly traded company with operations across multiple states and Canada.

B. The Alter Ego Significance

The significance of Gefen's simultaneous roles — TerrAscend CLO and AEY Capital Manager — under alter ego law is substantial. Alter ego doctrine permits a court to disregard the corporate form and hold a parent corporation liable for the acts of its subsidiary when the subsidiary is merely an instrumentality of the parent. The factors that courts consider include:

1. Common ownership and control: Gefen — TerrAscend's CLO — exercised direct managerial authority over AEY Capital, signing CRA consent orders as its "Manager."
2. Common officers and directors: Gefen served simultaneously as a senior officer of the parent (TerrAscend CLO) and a manager of the subsidiary (AEY Capital Manager).
3. Failure to observe corporate formalities: The dual role documented in the CRA consent order is itself evidence that the corporate distinction between TerrAscend and AEY Capital was not consistently observed.
4. Use of the subsidiary as a mere instrumentality: AEY Capital was used as the Michigan operating entity for a brand — Gage Cannabis Co. — that TerrAscend itself controlled.

C. The Assumed Name Renewal (January 15, 2026)

On January 15, 2026, AEY Holdings LLC — a TerrAscend-affiliated entity — filed an assumed name renewal with the Michigan Department of Licensing and Regulatory Affairs for "Gage Cannabis Company." The renewal was filed months after TerrAscend's August 2025 exit from the Michigan market, after the closure of all 20 dispensaries, and after the $0 impairment of the Gage brand.

The assumed name renewal — maintaining the "Gage Cannabis Company" name on Michigan's corporate registry despite the brand having been abandoned and written to $0 — is a factual datum. Its legal significance — whether it reflects ordinary corporate housekeeping, a defensive measure against the pending TTAB proceedings, or something else — is a determination for the appropriate authorities.

D. The Thacher Proffitt–Dentons Institutional Merger

Lynn Gefen was previously associated with Thacher Proffitt & Wood LLP, a New York-based law firm. Thacher Proffitt subsequently merged into Dentons LLP — the global law firm that served as Gage Growth Corp.'s TTAB counsel in Cancellation No. 91252169 and as the registered agent for Wolverine Partners Corp., one of the entities in the Gage trademark acquisition chain.

The institutional merger created a structural connection between Gefen's former firm and the law firm representing the entity opposing the original Gage brand holder. Whether this connection reflects an ordinary institutional relationship or a conflict-susceptible arrangement is a matter of public record that this paper documents without legal characterization.

V. The Michigan Exit: $167.7 Million in Losses, 250 Terminated Employees

A. TerrAscend's Michigan Operations: The Full Arc

TerrAscend operated the Gage brand in Michigan from approximately 2021 through August 2025. During this period, the company:

• Operated approximately 20 dispensaries under the "Gage" name
• Maintained cultivation and processing facilities
• Held the Cookies dispensary license as the exclusive Michigan retail partner — the cannabis brand founded by Gilbert Milam (known professionally as "Berner")
• Accumulated $167.7 million in cumulative losses in the Michigan market
• Employed approximately 250 Michigan residents

In August 2025, TerrAscend closed all 20 Michigan dispensaries and terminated approximately 250 employees. The termination was disclosed in TerrAscend's Form 8-K filed June 27, 2025 (Michigan exit plan approval) and confirmed in the FY2025 Form 10-K filed March 12, 2026. A press release issued June 30, 2025 (Exhibit 99.1 to the 8-K) stated that the Michigan exit plan "is expected to include a reduction of approximately 21% of the Company's overall workforce, which consists of about 1,200 employees as of June 30, 2025" — approximately 252 employees.

B. The $0 Impairment

TerrAscend's FY2025 Form 10-K (Accession No. 0001193125-26-104092) reported that the Gage brand intangible asset — classified as an indefinite-lived intangible — had been fully impaired as of the filing date. The 10-K's discontinued operations note discloses impairment of intangible assets in the Michigan segment totaling approximately $39.3 million in FY2024 and $35.8 million in FY2023, and $41.3 million in property and equipment impairment in FY2025. By FY2025, the Gage brand intangible had been written down to a net book value of zero — a full impairment of the asset that had been the centerpiece of a $545 million acquisition.

The impairment is significant for two reasons:

1. It confirms the terminal failure of the corporate capture model. A brand intangible that was valued as part of a $545 million transaction in 2021 was, by FY2025, entirely impaired on the acquiring corporation's own books — a four-year arc from acquisition to zero residual value.

2. It underscores the distinction between the corporate copy and the original brand. The impairment attaches to the registered mark held through the Gage Growth-TerrAscend chain — not to the original brand, which continues and whose holder is now pursuing cancellation of that registration through active TTAB proceedings.

C. The Cookies License Transfer

The Cookies dispensary license — TerrAscend's exclusive Michigan retail partnership — was transferred to Terra Men LLC and Terra Alta LLC, entities connected to Barton Morris and the same professional network that facilitated the original Gage brand appropriation. The transfer, documented in Michigan LARA business entity records, occurred in connection with TerrAscend's Michigan exit.

The Cookies license transfer is significant because it demonstrates that even as TerrAscend exited Michigan, wrote the Gage brand to $0, and terminated its employees, the valuable commercial assets — the Cookies dispensary license — were preserved and transferred to entities within the same network. The corporate structure was unwound, but the insiders retained the valuable pieces.

VI. The TTAB Opposition as a Component of the Extractive Chain

A. Opposition No. 91278331: The Corporate Entity Opposes the Original Holder

Opposition No. 91278331 was filed before the Trademark Trial and Appeal Board by Gage Growth Corp. — the entity formed by Hermiz and Reda with Bruce Linton as Executive Chairman — opposing the original Gage brand holder's trademark application. The opposition was filed while the original brand holder was defending against a criminal prosecution carrying a potential 19-year sentence.

The opposition deployed the resources of Dentons LLP — the world's largest law firm by attorney headcount, with approximately 12,000 lawyers across 80-plus countries — against an individual brand holder proceeding substantially without counsel. The resource asymmetry has been documented in detail in Papers 016 and 017.

The opposition is ongoing. Gage Growth Corp. failed to respond to the Show Cause Order. The TTAB issued a Show Cause Order on March 3, 2026, directing the respondent to show cause why the opposition should not be sustained. The deadline for response was April 2, 2026. As of the date of this paper, no response had been received and no default judgment had been formally entered.

B. The Extractive Function of the Opposition

The TTAB opposition functioned as an extension of the extractive chain into the adjudicative arena. The corporate entity — which had appropriated the Gage name, built a commercial operation on it, sold that operation to TerrAscend for $545 million, and then defaulted in the TTAB proceeding — used the legal infrastructure of the trademark system to oppose the original brand holder's registration. The cost of defending the opposition — in time, money, and attention — was borne by the individual brand holder. The cost of filing and litigating the opposition was borne by the corporate entity, which could deduct legal expenses and deploy teams of professionals while the individual respondent represented himself.

The opposition, viewed through the extractive chain framework, performed three functions:

1. Delay: The opposition extended the original brand holder's inability to secure federal trademark registration for the Gage name, impeding the brand's commercial development.
2. Resource extraction: The opposition forced the individual brand holder to allocate time and resources to TTAB defense — resources that could not be used for brand-building, business development, or other productive activity.
3. Insulation: The opposition provided a procedural mechanism through which the corporate actors could oppose the original brand holder's claims without exposing themselves to discovery, deposition, or cross-examination on the full evidentiary record — a shield that became absolute upon default.

C. The Failed Response as Extraction Completion

Gage Growth Corp.'s failure to respond to the Show Cause Order in Opposition No. 91278331 represents, in the view of industry observers, the terminal stage of the extractive chain. The corporate entity that appropriated the brand, sold it for $545 million, and then wrote it to $0 has now abandoned even the legal defense of the trademark — ceasing participation in the very proceeding it initiated.

Industry observers note that the default makes strategic sense within the extractive framework: the corporate entity has already extracted the value (the $545 million acquisition, the management fees, the secured creditor interest, the Cookies license transfer), and there is no remaining value to be extracted from continuing to defend the TTAB proceeding. The default is the final extraction — the abandonment of the legal position after all economic value has been removed.

VII. The Extractive Pattern: Industry Analysis

A. The Corporate Cannabis Extraction Model

Industry observers — including cannabis trade press analysts, academic researchers, and craft producer associations — have identified a recurring pattern in corporate cannabis transactions that this paper documents with respect to the Gage chain. The pattern, which industry observers describe as "extractive," follows a predictable sequence:

1. Capital entry: Outside capital — often from adjacent industries (alcohol, tobacco, pharmaceuticals) — enters a regulated cannabis market through investment in a publicly traded vehicle.
2. Local acquisition: The publicly traded vehicle acquires or displaces local operators, often at valuations that reflect the regulatory scarcity premium rather than the underlying business fundamentals.
3. Value extraction: The acquirer extracts value through management fees, related-party lending, licensing arrangements, and executive compensation — often structured to be structurally senior to operating performance.
4. Market exit: When the regulatory premium dissipates or the market fundamentals deteriorate, the acquirer closes operations, terminates employees, writes off assets, and exits — leaving communities with closed stores and lost jobs.
5. Insider preservation: Throughout the cycle, the individuals at the apex of the extractive chain maintain their personal financial positions — management fees continue, secured creditor claims remain intact, and real estate holdings are unaffected.

B. The Gage Chain as a Documented Instance of the Pattern

The Gage chain exhibits each element of the extractive pattern:

1. Capital entry: Constellation Brands' C$5.245 billion investment in Canopy Growth (August 2018) — alcohol capital entering cannabis.
2. Local acquisition: Gage Growth Corp. formed (October 2018) → Gage brand acquired through Wolverine Partners for approximately $192,485 → TerrAscend acquires Gage Growth Corp. for approximately $545 million (2021).
3. Value extraction: Jason Wild's dual equity-creditor position ($9.1M at 12.75% + 31% equity), JW Asset Management fees ($12M–$40M/year), Bruce Linton's 4,422,000 warrants, and the related-party Cookies license transfer to Terra Men/Terra Alta.
4. Market exit: TerrAscend closes all 20 Michigan dispensaries (August 2025), terminates approximately 250 employees, writes Gage brand to $0.
5. Insider preservation: Wild retains $17.6M Miami Beach mansion, management fees continue, Lynn Gefen continues as TerrAscend CLO, Bruce Linton continues board roles at Greenlane/SynBiotic/Red Light Holland.

The pattern is documented in public filings. The characterization of the pattern as "extractive" is an editorial judgment supported by the documentary record.

C. The International Dimension

The extractive pattern is not limited to Michigan. Industry observers have documented similar sequences in other jurisdictions:

• Canada: Canopy Growth's Linton-era licensing dominance displaced small craft producers across multiple provinces, as documented by the Canadian craft cannabis association and trade press coverage.
• California: The consolidation of the California cannabis market by multi-state operators has been analyzed by academic researchers and industry economists as following a parallel extractive pattern.
• Massachusetts, Illinois, New Jersey: Industry analysts have identified similar cycles of capital entry, local acquisition, value extraction, and market exit in multiple state-regulated cannabis markets.

The Gage chain, in this context, is not an outlier. It is a particularly well-documented instance of a pattern that extends across jurisdictions — a pattern made visible by the documentary record that the TTAB proceedings, SEC filings, and CRA consent orders have generated.

VIII. The Original Brand Holder's Position

A. Beyond Cancellation: Comprehensive Remedies

The original Gage brand holder — the individual whose brand was used continuously in Michigan cannabis commerce beginning in 2009, whose documented cultivars include Grape Stomper and Mendo Breath, and whose brand attracted a $10–15 million acquisition offer before the appropriation — is pursuing more than cancellation of the corporate registrant's mark. The TTAB proceedings are one component of a comprehensive legal strategy that includes:

• Trademark cancellation: Unwinding the corporate registration that secured the Gage name for the acquiring entities.
• Damages: Recovery for the economic harm caused by the appropriation and the subsequent litigation.
• Disgorgement of profits: Recovery of the profits the acquiring entities earned from the appropriated brand, including the management fees, secured creditor interest, and transaction proceeds documented in this paper.
• Alter ego liability: Holding the parent corporations and individual officers liable for the acts of the subsidiary entities that appropriated the brand, as supported by the AEY Capital / Lynn Gefen evidence documented in Section IV.
• Full chain exposure: Documenting and publicizing the complete extractive chain — from the C$5.245 billion Constellation investment through the $545 million TerrAscend acquisition to the $0 impairment — so that the individuals who structured, funded, and profited from the appropriation are identified and held accountable.

B. The LAW Intelligence Platform

The original brand holder is backed by the LAW intelligence platform — an autonomous legal intelligence system that has assembled the documentary record, verified the fact chains, and prepared the legal filings that support the comprehensive remedy strategy. The platform, built on 300-plus Python modules, a 97-volume Corpus Juris Secundum law library, and a 297,000-event master timeline, provides litigation support at a structural cost that enables an individual brand holder to sustain proceedings against publicly traded corporations and global law firms.

The LAW platform is not a law firm. It is an intelligence infrastructure — a system that performs the legal research, evidence analysis, document drafting, and strategic assessment that traditional law firms bill at partner and associate rates, but does so at a structural cost that makes the legal system accessible to an individual litigant. The papers in this series — 016, 017, and the present paper — are products of that infrastructure.

C. The Distinguished Brand — Not Minimized

The original Gage brand holder is not a victim. The individual built a cannabis brand that operated internationally, won awards, developed recognized cultivars, attracted multi-million-dollar acquisition offers, and was targeted for takeover precisely because of its value. The appropriation documented in this paper occurred because the brand was valuable — valuable enough to be stolen, financialized, and ultimately discarded.

The TTAB proceedings are not a request for recognition. They are a legal mechanism through which the original brand holder is asserting rights that the documentary record establishes — rights that the corporate actors' default has left undefended. The original brand holder is backed by the LAW intelligence platform and is pursuing comprehensive remedies including trademark cancellation, damages, disgorgement, alter ego liability, and exposure of the full acquisition chain. The legal system will determine the outcome. The documentary record provides the foundation.

IX. Conclusion

The Gage cannabis extractive chain — from C$5.245 billion in alcohol funding through a $545 million cannabis acquisition to $0 book value — documents a sequence in which outside capital entered a regulated market, appropriated a locally built brand, financialized it through a publicly traded corporation, extracted value through management fees, secured lending, and licensing arrangements, and then exited, leaving approximately $167.7 million in cumulative losses, 20 closed stores, and 250 terminated employees.

The constellation of individuals who structured the chain — Bruce Linton (Canopy Growth founder, Gage Growth Corp. Executive Chairman), Jason Wild (TerrAscend Executive Chairman, dual equity-creditor, $17.6M Miami Beach resident), and Lynn Gefen (TerrAscend CLO, AEY Capital Manager, CRA consent order signatory) — operated through a complex structure of entities (Canopy Growth, Canopy Rivers, Gage Growth Corp., Wolverine Partners Corp., TerrAscend Corp., AEY Capital LLC, AEY Holdings LLC, Terra Men LLC, Terra Alta LLC, FocusGrowth, JW Asset Management, Carma Holdco) and law firms (Dentons LLP, Saul Ewing LLP, Thacher Proffitt & Wood LLP) that, viewed together, constitute what this paper has documented as an extractive chain.

The original brand holder — backed by the LAW intelligence platform and pursuing comprehensive remedies including trademark cancellation, damages, disgorgement, alter ego liability, and exposure of the full acquisition chain — continues to press these claims through active TTAB proceedings. The corporate actors' failure to respond to the Show Cause Order in Opposition No. 91278331 has left those claims procedurally undefended.

The documentary record is what it is. This paper has assembled it in one place.

D. Causal Chain Summary

The extractive chain documented in this paper connects specific conduct by identified actors to specific harm:

• Hermiz and Reda's formation of Gage Growth Corp. (October 2018) adopted the existing Gage name without authorization, appropriating a brand built over approximately nine years, triggering the chain of successive ownership transfers that followed.
• Bruce Linton's role as Gage Growth Corp. Executive Chairman and warrant holder (4,422,000 warrants) lent the credibility of the Canopy Growth founder to the Michigan entity, facilitating the $545 million TerrAscend acquisition in which Linton held personal financial interests.
• Jason Wild's dual equity-creditor architecture ($9.1M FocusGrowth secured debt at 12.75% + 31% equity position + JW Asset Management fees) created a structural conflict in which Wild's personal financial position was protected regardless of TerrAscend's operating performance, including in an adverse TTAB scenario.
• Lynn Gefen's simultaneous roles as TerrAscend CLO and AEY Capital Manager created the alter ego evidence that supports holding the parent corporation liable for the Michigan operating entity's regulatory compliance and brand management decisions.
• The TTAB opposition (Opposition No. 91278331) deployed Saul Ewing and Dentons LLP resources against an individual pro se respondent, forcing the original brand holder to defend the proceeding while the corporate actors were represented by teams of professionals.
• The Michigan exit left approximately $167.7 million in cumulative losses, 20 closed dispensaries, and approximately 250 terminated employees, while Wild's management fees ($12M-$40M/year) and Miami Beach residence ($17.6M) remained unaffected.

References

1. Constellation Brands, Inc., Press Release, "Constellation Brands to Invest C$5 Billion in Canopy Growth," August 15, 2018. Available: https://www.constellationbrands.com/newsroom/

2. Canopy Growth Corporation, SEDAR filings (peak market capitalization ~C$17 billion as of October 2018). Available: https://www.sedarplus.ca/ (Ticker: WEED)

3. TerrAscend Corp., Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed March 12, 2026, CIK 0001778129, Accession No. 0001193125-26-104092. Available: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001778129

4. TerrAscend Corp., Current Report on Form 8-K, filed June 27, 2025, CIK 0001778129, Accession No. 0000950170-25-091718 (Michigan exit plan approval). Available: https://www.sec.gov/Archives/edgar/data/1778129/000095017025091718/0000950170-25-091718-index.htm

5. TerrAscend Corp., Schedule 13D/A (Amendment No. 2), filed by JW Opportunities Master Fund, Ltd., JW Partners, LP, Pharmaceutical Opportunities Fund, LP, and Jason Wild, May 31, 2023, CIK 0001778129, Accession No. 0000950170-23-031698. Available: https://www.sec.gov/Archives/edgar/data/1778129/000095017023031698/0000950170-23-031698-index.htm

6. TerrAscend Corp., Form 4 filings, Jason Wild, dated November 21 and November 24, 2025 (sale of 546,174 shares). SEC CIK 0001778129. Available via EDGAR search.

7. TerrAscend Corp., Press Release dated June 30, 2025 (Exhibit 99.1 to Form 8-K, Accession No. 0000950170-25-091718). Confirms reduction of approximately 21% of ~1,200-employee workforce (~252 employees) in connection with Michigan exit. Available: https://www.sec.gov/Archives/edgar/data/1778129/000095017025091718/tsndf-ex99_1.htm

8. Michigan Cannabis Regulatory Agency, Consent Order ENF 22-00499, In re AEY Capital LLC, signed August 28, 2023. Available: https://www.michigan.gov/cra/

9. Michigan Department of Licensing and Regulatory Affairs, Assumed Name Renewal, AEY Holdings LLC, "Gage Cannabis Company," filed January 15, 2026. Available: https://cofs.lara.state.mi.us/

10. Michigan Department of Licensing and Regulatory Affairs, Terra Men LLC and Terra Alta LLC, business entity records. Available: https://cofs.lara.state.mi.us/

11. Trademark Trial and Appeal Board, Opposition No. 91278331, Gage Prestige Holdings LLC v. Gage Growth Corp., Show Cause Order, March 3, 2026; docket entry 40. Available: https://ttabvue.uspto.gov/ttabvue/v?pno=91278331

12. Trademark Trial and Appeal Board, Cancellation No. 91252169, Decision dated April 29, 2025; terminated September 30, 2025. Available: https://ttabvue.uspto.gov/ttabvue/v?pno=91252169

13. Ontario Corporations Registry, Gage Growth Corp., formed under the Canada Business Corporations Act, October 2018. Available: https://www.ic.gc.ca/app/scr/cc/CorporationsCanada/fdrlCrpDtls.html

14. Canopy Rivers Inc., SEDAR filings (ownership interests in Radicle Cannabis and TerrAscend Corp.). Available: https://www.sedarplus.ca/ (Ticker: RIV)

15. 11 U.S.C. § 507 (Bankruptcy Code — priority of claims). Available: https://www.law.cornell.edu/uscode/text/11/507

16. 15 U.S.C. § 1051 et seq. (Lanham Act — trademark registration, priority, cancellation, and remedies). Available: https://www.law.cornell.edu/uscode/text/15/1051

17. New York State Unified Court System, Attorney Registration, Lynn Katzler Gefen, Registration No. 2839033, admitted 1997. Available: https://iapps.courts.state.ny.us/attorney/

18. Dentons LLP, Our History (Thacher Proffitt & Wood merger). Available: https://www.dentons.com/en/about-dentons/our-history

19. Carma Holdco, Inc., board of directors listing (Jason Wild). Available via corporate records.

20. Miami-Dade County Property Appraiser, 1051 N Venetian Dr, Miami Beach, FL 33139. Available via public property records.

21. LAW Intelligence. (2026). What Is Gage Cannabis? Two Brands, One Name, and a $545 Million Question. LAW Intelligence, 2(5), 1–32. (Paper-016)

22. LAW Intelligence. (2026). Lawfare and Corporate Espionage in the Gage TTAB Proceedings: A Tactical Analysis. LAW Intelligence, 2(6), 1–38. (Paper-017)

23. LAW Intelligence investigation, evidence on file with the authors. Primary sources cited throughout this paper are publicly available through SEC EDGAR, TTABVUE, Michigan LARA, SEDAR, and the sources listed above.

Citation

LAW Intelligence Research Division. (2026). The Gage Cannabis Extractive Chain: From C$5.245B in Alcohol Funding to a $545M Cannabis Acquisition to $0 Book Value. LAW Intelligence, 2(7), 1–38.

Distribution

Published: LAW Intelligence, LAW Intelligence 2(7) Status: published